The role of blood service? And regulatory bodies in stem cell transplantation

Vox Sanguinis

Volumn 94, Issue 1, 2008, Pages 6-17

  Austin, E B ^a   Guttridge, M ^a   Pamphilon, D ^a   Watt, S M ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood services; EU directives; FACT; Haemopoietic stem cells; JACIE; Regulatory bodies

Indexed keywords

BLOOD BANK; BLOOD TRANSFUSION; BONE MARROW; CELL THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; EUROPE; EUROPEAN UNION; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH SERVICE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LAW; MEDICAL RESEARCH; PERIPHERAL BLOOD STEM CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; STEM CELL TRANSPLANTATION; UNITED KINGDOM; HISTORY; LEGAL ASPECT; NATIONAL HEALTH SERVICE; STANDARD;

BLOOD BANKS; EUROPEAN UNION; GREAT BRITAIN; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; STATE MEDICINE;

EID: 37249052844     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.00974.x     Document Type: Review

References (60)

1. Horowitz MM: Uses and growth of hematopoietic cell transplantation in Blume KG, Foreman SJ, Applebaum SR (eds): Thomas' Hemopoietic Cell Transplantation, 3rd edn. Oxford, Blackwell Science, 2004
2. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A: Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant 2005 36: 575 590
3. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D: Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007 39: 71 87
4. Mauro MJ, Maziarz RT: Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used? Mayo Clin Proc 2006 8: 404 416
5. Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J, Kolb HJ, Lahaye T, Maywald O, Reiter A, Hossfeld DK, Huber C, Loffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler ME, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M, Hirschmann WD, Lechner K, Wassmann B, Falge C, Kirchner HH, Gratwohl A: Drug treatment is superior to allografting as first line therapy in chronic myeloid leukemia. Blood 2007 109: 4686 4692
6. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J, Rocha V, Saccardi R, Schouten H, Schmitz N, Socie G, Sureda A, Apperley J for the European Group for Blood Marrow Transplantation: Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006 37: 439 449
7. Goldman JM, Madrigal JA, Pamphilon D: Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors. Br J Haematol 2006 135: 651 652
8. Cashen AF, Lazarus HM, Devine SM: Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? Bone Marrow Transplant 2007 39: 577 588
9. Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P: AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 2006 107: 3772 3778
10. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, Cooper S, English D, Kurtzberg J, Bard J, Boyse EA: Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989 321: 1174 1178
11. Watt SM, Contreras M: Stem cell medicine: umbilical cord blood and its stem cell potential. Semin Fetal Neonatal Med 2005 10: 209 220
12. Burnstein CG, Baker KS, Wagner JE: Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 2007 14: 162 169
13. Haspel RL, Ballen KK: Double cord blood transplants: filling a niche? Stem Cell Rev 2006 2: 81 86
14. Majhail NS, Brunstein CG, Wagner JE: Double umbilical cord blood transplantation. Curr Opin Immunol 2006 18: 571 575
15. Smythe J, Armitage S, McDonald D, Pamphilon D, Guttridge M, Brown J, Green A, Brown C, Warwick RM, Lankester A, Fehily D, Contreras M, Navarrete C, Watt SM: Directed sibling cord blood banking for transplantation: the ten year experience in the National Blood Service in England. Stem Cells 2007 25: 2087 2093
16. Rocha V, Gluckman E, Eurocord European Blood Marrow Transplant Group: Clinical use of umbilical cord blood hemopoietic stem cells. Biol Blood Marrow Transplant 2006 12: 34 41
17. Netcord inventory and use June 2007, accessed at https://www.netcord.org/ inventory.html
18. Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, Osman H, Assenmacher M, Billingham L, Steward C, Crawley C, Olavarria E, Goldman J, Chakraverty R, Mahendra P, Craddock C, Moss PA: Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J Exp Med 2005 202: 379 386
19. Guttridge MG, Sidders C, Booth-Davey E, Pamphilon D, Watt SM: Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation. Bone Marrow Transplant 2006 38: 175 181
20. Guttridge M, Belfield H, Hollyman D, Lankester A, Watt S: An internal positive control for the enumeration of CD45(+) and CD34(+) cells by flow cytometry allows monitoring of reagent and operator performance. Cytotherapy 2007 9: 275 282
21. Keeney M, Gratama JW, Sutherland DR: Critical role of flow cytometry in evaluating peripheral blood hematopoietic stem cell grafts. Cytometry 2004 58: 72 75
22. Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990 76: 2462 2245
23. Blair A, Goulden NJ, Libri NA, Oakhill A, Pamphilon DH: Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation. Blood Rev 2005 19: 289 300
24. Speak AO, Salio M, Neville DC, Fontaine J, Priestman DA, Platt N, Heare T, Butters TD, Dwek RA, Trottein F, Exley MA, Cerundolo V, Platt FM: Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc Natl Acad Sci USA 2007 104: 5971 5976
25. Kotsianidis I, Silk JD, Spanoudakis E, Patterson S, Almeida A, Schmidt RR, Tsatalas C, Bourikas G, Cerundolo V, Roberts IA, Karadimitris A: Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells. Blood 2006 107: 3138 3144
26. Mansoor W, Gilham DE, Thistlethwaite FC, Hawkins RE: Engineering T cells for cancer therapy. Br J Cancer 2005 93: 1085 1091
27. Woan K, Reddy V: Potential therapeutic fole of natural killer cells in cancer. Expert Opin Biol Ther 2007 7: 17 29
28. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K: Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006 81: 1390 1397
29. Council of Europe Committee of Ministers: Resolution (78) 29 on harmonisation of legislations of member states relating to removal, grafting and transplantation of human substances. Available from http://www.coe.int/t/e/ social_cohesion/health/recommendations/Res(78)29.pdf
30. Council of Europe: Recommendation No R(94)1 on human tissue banks. Available from http://www.coe.int/T/E/Social_Cohesion/Health/Recommendations/ Rec(1994)01.asp
31. Council of Europe: Guide to Safety and Quality Assurance for the Transplantation of Organs, Tissues and Cells, 3rd edn. Council of Europe, 2007
32. Department of Health: Code of Practice for Tissue Banks Providing Tissues of Human Origin for Therapeutic Purposes, London, Medicines Control Agency, 2001
33. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004; on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union 2004 7.4.2004: 48
34. Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union 2006 09.02.2006: 40
35. Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union 2006 25.10.2006: 32
36. Statutory Instrument 2004 No. 919: Human Tissue Act 2004. London, The Stationary Office, 2004
37. The Human Tissue Act 2004 (Persons who Lack Capacity to Consent Transplants) Regulations 2006: Statutory instruments 2006 No. 1659. The Stationary Office, 2006
38. The Human Tissue Act 2004 (Ethical Approval, Exceptions from Licensing Supply of Information about Transplants) Regulations 2006: Statutory instruments 2006 No. 1260 The Stationary Office, 2006
39. Human Tissue Authority: http://www.hta.gov.uk/
40. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003; setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official Journal of the European Union 2003 8.2.2003: 30
41. Directive 2004/33/EC 'implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components Official Journal of the European Union 2004 30.03.2004: 25
42. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Union 2001 28.11.2001: 67
43. Directive 2001/20/EC OF the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Union 2001 1.5.2001: 34
44. Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. Official Journal of the European Union 2003 14.10.2003: 22
45. European Medicines Agency: Guideline on Human Cell-Based Medicinal Products. Available from http://www.emea.europa.eu/pdfs/human/cpwp/41086906en. pdf
46. Report of the Research Group on Cellular Immune Therapies (SP-CIT): The Provision of Safe Products Meeting High Quality Standards. Available from http://www.coe.int/t/e/social_cohesion/health/CIT%20report%20-%20final.doc
47. Foundation for the Accreditation of Cellular Therapy (FACT) and Joint Accreditation Committee - ISCT and EBMT (JACIE): International Standards for Cellular Therapy Product Collection, Processing, and Administration. 3rd edn, 2007. Available at http://www.factwebsite.org/uploadedFiles/Standards/ Stds%203rd%20Ed_FinalCopy.pdf
48. Samson D, Slaper-Cortenbach I, Pamphilon D, McGrath E, McDonald F, Urbano Ispizua A: Current status of JACIE accreditation in Europe: a special report from the Joint Accreditation Committee of the ISCT and the EBMT (JACIE). Bone Marrow Transplant 2007 39: 133 141
49. FACT-JACIE International Standards Significant Changes between the 2nd and 3rd editions, 19 February 2007, Available under 'Document centre http://www.jacie.org/
50. NetCord-FACT International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release, 3rd edn, 2006. Available at http://www.factwebsite.org/uploadedFiles/Standards/ CB%20Stds_3rd%20Ed_FINAL%201%2029%2007.pdf
51. Slopecki A, Smith K, Moore S: The value of good manufacturing practice to a blood service in managing the delivery of quality. Vox Sang 2007 92: 187 196
52. James V: Guidelines for the Blood Transfusion Services in the United Kingdom, 7th edn. London, The Stationary Office, 2005
53. Statutory Instrument 2005 No. 50: Blood Safety and Quality Regulations 2005. London, The Stationary Office, 2005
54. Medicines and Healthcare Products Regulatory Agency: Rules and Guidance for Pharmaceutical Manufacturers and Distributors, Edition 2007. London, Pharmaceutical Press, 2007
55. Department of Health: UK Stem Cell Initiative: Report and Recommendations, November 2005. Available at http://www.advisorybodies.doh.gov. uk/uksci/uksci-reportnov05.pdf
56. Department of Health: Report of the review of NHS pathology services in England. Available at http://www.dh.gov.uk/en/Publicationsandstatistics/ Publications/PublicationsPolicyAndGuidance/DH_4137606
57. McKenna D, Jr., Kadidlo D, Sumstad D, McCullough J: Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory. Cytotherapy 2003 5: 314 322
58. Cassens U, Ahlke C, Garritsen H, Krakowitzky P, Wullenweber J, Fischer RJ, Peters G, Sibrowski W: Processing of peripheral blood progenitor cell components in improved clean areas does not reduce the rate of microbial contamination. Transfusion 2002 42: 10 17
59. Ritter M, Schwedler J, Beyer J, Movassaghi K, Mutters R, Neubauer A, Schwella N: Bacterial contamination of ex vivo processed PBPC products under clean room conditions. Transfusion 2003 43: 1587 1595
60. Giordano R, Lazzari L, Rebulla P: Clinical grade cell manipulation. Vox Sang 2004 87: 65 72